Wall Street Analysts Predict an 84.18% Upside in BioCryst (BCRX): Here's What You Should Know
Portfolio Pulse from
Wall Street analysts predict a significant upside of 84.18% for BioCryst Pharmaceuticals (BCRX) based on average price targets. Positive trends in earnings estimate revisions could support this potential increase.
February 26, 2025 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BioCryst Pharmaceuticals (BCRX) is projected to have an 84.18% upside according to Wall Street analysts' average price targets. Positive earnings estimate revisions may support this potential growth.
The article highlights a significant potential upside for BCRX based on analyst price targets, which is a strong indicator for investors. Additionally, positive trends in earnings estimate revisions further support the potential for stock price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100